Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.37 USD | +0.64% | +0.35% | -24.58% |
May. 30 | Baird Starts Privia Health Group With Outperform Rating, $23 Price Target | MT |
May. 20 | Barclays Adjusts Price Target on Privia Health to $19 From $22, Maintains Equalweight Rating | MT |
Financials (USD)
Sales 2024 * | 1.66B | Sales 2025 * | 1.87B | Capitalization | 2.07B |
---|---|---|---|---|---|
Net income 2024 * | 23M | Net income 2025 * | 36M | EV / Sales 2024 * | 0.99 x |
Net cash position 2024 * | 429M | Net cash position 2025 * | 560M | EV / Sales 2025 * | 0.81 x |
P/E ratio 2024 * |
90.5
x | P/E ratio 2025 * |
59.7
x | Employees | 1,102 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.15% |
Latest transcript on Privia Health Group, Inc.
1 day | +0.64% | ||
1 week | +0.35% | ||
1 month | -3.66% | ||
3 months | -22.18% | ||
6 months | -20.32% | ||
Current year | -24.58% |
Managers | Title | Age | Since |
---|---|---|---|
Parth Mehrotra
CEO | Chief Executive Officer | 45 | 17-12-31 |
Director of Finance/CFO | 54 | 13-12-31 | |
Chris Voigt
CTO | Chief Tech/Sci/R&D Officer | - | 12-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Sullivan
BRD | Director/Board Member | 60 | 20-12-31 |
David Wichmann
BRD | Director/Board Member | 61 | 23-07-31 |
David King
CHM | Chairman | 67 | 20-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 746 M€ | -.--% | - | |
0.03% | 234 M€ | +8.48% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 17.37 | +0.64% | 752,020 |
24-05-30 | 17.26 | +5.24% | 952,005 |
24-05-29 | 16.4 | -5.09% | 781,101 |
24-05-28 | 17.28 | -0.17% | 704,954 |
24-05-24 | 17.31 | +7.45% | 1,192,025 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.58% | 2.07B | |
+25.52% | 88.99B | |
-24.52% | 74.82B | |
-5.56% | 25.03B | |
+4.31% | 17.88B | |
-14.25% | 16.43B | |
+2.97% | 15.77B | |
+79.20% | 13.21B | |
+70.11% | 13.08B | |
+40.44% | 12.9B |
- Stock Market
- Equities
- PRVA Stock